Literature DB >> 16173235

Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies.

S Sato1, M Hirakata, M Kuwana, K Nakamura, A Suwa, S Inada, T Mimori, Y Ikeda.   

Abstract

OBJECTIVE: The clinical and laboratory features of seven Japanese patients with anti-aminoacyl-tRNA synthetase (ARS) autoantibodies against PL-7 (anti-threonyl-tRNA synthetase) were analyzed and compared with previously published findings.
METHODS: Serum samples from 1,135 Japanese patients with various autoimmune diseases were screened for anti-PL-7 antibodies using RNA and protein immunoprecipitation assays. The patients whose sera contained anti-PL-7 antibodies were assessed regarding clinical symptoms and clinical course.
RESULTS: Sera from seven patients were found to have anti-PL-7 antibodies. These autoantibodies were associated with polymyositis/dermatomyositis (PM/DM) and/or interstitial lung disease (ILD). The clinical diagnoses of these seven patients were PM - systemic sclerosis (SSc) overlap (5 patients), DM (1 patient) and idiopathic pulmonary fibrosis (IPF) (1 patient). All patients had ILD with a chronic course and six also had arthritis (85%) and five sclerodactyly (71%).
CONCLUSIONS: These results indicate that anti-PL-7 autoantibodies are closely associated with PM-SSc overlap as well as ILD, arthritis and sclerodactyly in our series of Japanese patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16173235

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  13 in total

1.  Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.

Authors:  Thomas J Richards; Aaron Eggebeen; Kevin Gibson; Samuel Yousem; Carl Fuhrman; Bernadette R Gochuico; Noreen Fertig; Chester V Oddis; Naftali Kaminski; Ivan O Rosas; Dana P Ascherman
Journal:  Arthritis Rheum       Date:  2009-07

Review 2.  Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment.

Authors:  Tsuneyo Mimori; Ran Nakashima; Yuji Hosono
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

Review 3.  A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.

Authors:  Minoru Satoh; Shin Tanaka; Angela Ceribelli; S John Calise; Edward K L Chan
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 4.  Clinical heterogeneity and outcomes of antisynthetase syndrome.

Authors:  Baptiste Hervier; Olivier Benveniste
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

Review 5.  Myositis specific autoantibodies.

Authors:  Ira N Targoff
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

6.  High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis.

Authors:  Ayako Nakajima; Koichiro Yoshino; Makoto Soejima; Yasushi Kawaguchi; Takashi Satoh; Masataka Kuwana; Hisashi Yamanaka
Journal:  Rheumatol Int       Date:  2011-04-11       Impact factor: 2.631

Review 7.  Antisynthetase syndrome: A distinct disease spectrum.

Authors:  Kun Huang; Rohit Aggarwal
Journal:  J Scleroderma Relat Disord       Date:  2020-02-18

Review 8.  Antisynthetase antibody syndrome: case report and review of the literature.

Authors:  Laura Uribe; Diana Maria Ronderos; Maria Claudia Díaz; Juan Martín Gutierrez; Christina Mallarino; Daniel Gerardo Fernandez-Avila
Journal:  Clin Rheumatol       Date:  2013-02-20       Impact factor: 2.980

9.  The Association of Anti-Aminoacyl-Transfer Ribonucleic Acid Synthetase Antibodies in Patients With Rheumatoid Arthritis and Interstitial Lung Disease.

Authors:  Masakazu Matsushita; Naoto Tamura; Michihiro Ogasawara; Kurisu Tada; Ken Yamaji; Yoshinari Takasaki
Journal:  Arch Rheumatol       Date:  2017-10-12       Impact factor: 1.472

10.  Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.

Authors:  Yasuhito Hamaguchi; Manabu Fujimoto; Takashi Matsushita; Kenzo Kaji; Kazuhiro Komura; Minoru Hasegawa; Masanari Kodera; Eiji Muroi; Keita Fujikawa; Mariko Seishima; Hidehiro Yamada; Ryo Yamada; Shinichi Sato; Kazuhiko Takehara; Masataka Kuwana
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.